Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Abstract

The use of plants for medicinal purposes dates back thousands of years but genetic engineering of plants to produce desired biopharmaceuticals is much more recent. As the demand for biopharmaceuticals is expected to increase, it would be wise to ensure that they will be available in significantly larger amounts, on a cost-effective basis. Currently, the cost of biopharmaceuticals limits their availability. Plant-derived biopharmaceuticals are cheap to produce and store, easy to scale up for mass production, and safer than those derived from animals. Here, we discuss recent developments in this field and possible environmental concerns.

Extracted Key Phrases

4 Figures and Tables

0200400'02'04'06'08'10'12'14'16
Citations per Year

3,669 Citations

Semantic Scholar estimates that this publication has 3,669 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Daniell2001MedicalMF, title={Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.}, author={Henry Daniell and Stephen J. Streatfield and Keith L. Wycoff}, journal={Trends in plant science}, year={2001}, volume={6 5}, pages={219-26} }